<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="24505">Heparins</z:chebi> represent an efficient treatment of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mp ids='MP_0005048'>thrombosis</z:mp> and obstetric complications in <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) </plain></SENT>
<SENT sid="1" pm="."><plain>Enhanced microvesiculation of cell membranes, as detected by reduced membrane <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e>, can contribute to <z:hpo ids='HP_0100724'>hypercoagulability</z:hpo> in APS </plain></SENT>
<SENT sid="2" pm="."><plain>Healthy donor IgG antibodies significantly increased beta2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I (beta2-GPI)-induced membrane <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e>, indicating that IgG antibodies might supplement the role of beta2-GPI in the regulation of membrane microvesiculation in healthy individuals </plain></SENT>
<SENT sid="3" pm="."><plain>Anti-beta2-GPI IgG antibodies significantly reduced beta2-GPI-induced membrane <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e>, suggesting a direct role of anti-beta2-GPI antibodies in enhancing membrane microvesiculation in APS </plain></SENT>
<SENT sid="4" pm="."><plain>Therapeutic concentration of nadroparin completely restored beta2-GPI-induced membrane <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> in the presence of anti-beta2-GPI IgG antibodies </plain></SENT>
<SENT sid="5" pm="."><plain>A novel <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> mechanism of nadroparin in APS is suggested that supplements its direct effect on the coagulation cascade </plain></SENT>
<SENT sid="6" pm="."><plain>Restoration of <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> between negatively charged membranes in the presence of nadroparin might decrease shedding of microvesicles into the surrounding solution and could thus contribute to the efficacy of <z:chebi fb="5" ids="28304">heparin</z:chebi> treatment in APS </plain></SENT>
</text></document>